HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and CFO Nicole Labrosse sold $1.6M of Halozyme Therapeutics, Inc.
Sold$1,557,940
$51.93Price
30,000Shares
−66%Stake
What HALO did after the filing
- The stock from Fri, Jun 28 close, $52.36
- +7.1%
- S&P 500, same days
- −2.0%
Measured over 30 trading days, to the Aug 12 close.
Traded Wed, Jun 26. Filed Fri, Jun 28, 12:06 PM ET, during the session. Returns use the Jun 28 close and the Aug 12 close. Not investment advice.